Chitinase 3-like-1, A Key to Fighting Pneumonia
While working with mice, scientists at Yale University found that the protein Chitinase 3-like-1 (Chi3l1) was crucial in regulating the immune response to Streptococcus pneumonia,…
While working with mice, scientists at Yale University found that the protein Chitinase 3-like-1 (Chi3l1) was crucial in regulating the immune response to Streptococcus pneumonia,…
A newly published study from scientists at Caltech suggests that specific changes in an overactive immune system can contribute to autism-like behaviors in mice and…
Developed by a team of scientists at Yale, a new biodegradable nanoparticle, called a nanogel, delivers a combination of two therapeutic agents to tumor sites,…
A new study from the Harvard Medical School suggests that the superabundant microbes lining our gastrointestinal tract are ultimately our evolutionary partners, shedding light on…
A recently published study examines why Salmonella becomes dangerously virulent. While examining signals from outside the bacteria, they found that changes in the level of…
A new study from a team of microbiologists and immunologists suggests that treatment aimed at increasing Th17 cells in the gut may improve the control…
A new study using the antibody drug BMS-936558 (MDX-1106, anti-PD-1), resulted in tumor shrinkage of at least 30 percent in 18 percent of lung cancer…
Pathogens that cause plague or cholera use miniature syringes to introduce molecular agents into their host cell, disabling the immune defense of the infected cell….
Findings suggest that our own immune system may be working against us when it comes to protection from skin cancer. The scientists found that in…
Novel technology could potentially seek out cancer cells and cause them to self-destruct. Inspired by the mechanics of the body’s own immune system, researchers at…
Researchers at Antwerp Institute of Tropical Medicine, Antwerp University Hospital and Antwerp University have begun the testing of a new ‘therapeutic vaccine’ against HIV on…
Dr. Chil-Yong Kang and his team at The University of Western Ontario have been studying HIV for the last twenty years and working on a…